期刊文献+

深部热疗联合局部化疗治疗恶性胸腹水的临床观察 被引量:4

Clinical observation of malignant pleural and ascites treated by deep hyperthermia combined with local chemotherapy
下载PDF
导出
摘要 目的研究恶性胸腹水予以深部热疗联合局部化疗的临床效果。方法选取本院2017年10月至2019年3月收治的恶性胸腹水患者40例,数字随机法分为对照组与观察组,各20例。对照组采取局部化疗治疗,观察组在对照组基础上联合深部热疗治疗。观察两组治疗效果、生活质量、不良事件发生率。结果观察组总有效率为95.00%,高于对照组(P<0.05);观察组治疗后的生理功能(81.43±3.75)分、社会关系(83.09±3.43)分、心理状况(82.06±2.57)分、物质生活(84.86±4.03)分均优于对照组(P<0.05);观察组不良事件发生率为10.00%,低于对照组(P<0.05)。结论恶性胸腹水予以深部热疗联合局部化疗治疗,效果显著,可有效控制病情,降低不良事件发生风险。
作者 赵丽丽 丁宁 Zhao Lili;Ding Ning
出处 《当代医学》 2020年第9期158-160,共3页 Contemporary Medicine
  • 相关文献

参考文献6

二级参考文献57

  • 1Suma L Sangisetty,Thomas J Miner.Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures[J].World Journal of Gastrointestinal Surgery,2012,4(4):87-95. 被引量:45
  • 2范剑虹,吴霞,何陈云.中晚期宫颈癌的同步放化疗[J].中国临床医学,2006,13(6):983-984. 被引量:17
  • 3孙燕,周际昌.临床肿瘤内科学[M].北京:人民卫生出版社,1997.198-199
  • 4Taylor PT, Haverstiek D. New guidelines to evaluate the response to treatment in solid tumors= ovarian cancer[-J]. J NatlCancer Inst, 2005, 97(2): 151.
  • 5Wakayama A, Inamine M, Kudaka W, et al. Concurrent chemoradiotherapy for non-bulky stage 1B/II cervical cancer without pelvic node enlargement[J]. Anticancer Res, 2013, 33(11). 5123-5126.
  • 6Wang P, Meng Z Q, Chen Z, et al. Survival rate of pancreatic cancer in elderly patients[J]. Hepato-gastroenterology, 2008, 55(82/83): 681-686.
  • 7Wust P, Hidebrandt B, Streenivasa G, et al. Hyperthermia in combined treatment of cancer[J]. Lancet Oncology, 2002, 3(8): 489-497.
  • 8Trotti A, Bentzen S M. The need for adverse effects reporting standards in oncology clinical trials[J]. Journal of Clinical Oncology, 2004, 22(1): 19-22.
  • 9Burris H,Moore M J,Anderson J, et al. Improvements in survival and clinical benefit with gemcitabine as first--line therapy for patients with advanced pancreas cancer: A randomized trial[J]. Journal of Clinical Oncology, 1997, 5(6): 2403-2413.
  • 10Herrmann R, Bodoky G, Ruhstaller T, et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: Arandomized, muhicenter, phase lll trial of the Swiss Group for clinical cancer research and the central european cooperative oncology group[Jl. Journal of Clinical Oncologv, 2007, 25(16): 2212-2217.

共引文献35

同被引文献27

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部